Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

MiMedx Group Q4 Adj $0.07, Inline, Sales $92.91M Beat $89.42M Estimate

Author: Benzinga Newsdesk | February 26, 2025 05:11pm
MiMedx Group (NASDAQ:MDXG) reported quarterly earnings of $0.07 per share which met the analyst consensus estimate. This is a 75 percent increase over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $92.91 million which beat the analyst consensus estimate of $89.42 million by 3.90 percent. This is a 7.00 percent increase over sales of $86.83 million the same period last year.

Posted In: MDXG


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist